SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
path_2997_sm_suppinfomats1ab.tif5353KSupporting Information: Figure S1. Expression of NOTCH pathway components in NPC and immortalized nasopharyngeal epithelial cell lines.
path_2997_sm_suppinfomatis1c.tif6658KSupporting Information: Figure S1. Expression of NOTCH pathway components in NPC and immortalized nasopharyngeal epithelial cell lines.
path_2997_sm_suppinfomatis2.tif2257KSupporting Information: Figure S2. EBV-positive NPC cell line C666-1 is resistant to DAPT treatment.
path_2997_sm_suppinfomatis3.tif3483KSupporting Information: Figure S3. Down-regulation of multiple NOTCH3 targets in the C666-1 cells treated with NOTCH3 siRNA.
path_2997_sm_suppinfomatis4.tif2045KSupporting Information: Figure S4. NOTCH3 induces NFKB1 promoter activities in NPC cells.
path_2997_sm_suppinfomatis5.tif2479KSupporting Information: Figure S5. NUMB expression is regulated by proteasomal degradation in C666-1 cells.
path_2997_sm_suppinfomatis6ab.tif2795KSupporting Information: Figure S6. NOTCH3 transcription was not induced by EBV latent genes.
path_2997_sm_suppinfomatis6c.tif1414KSupporting Information: Figure S6. NOTCH3 transcription was not induced by EBV latent genes.
path_2997_sm_suppinfomatabs1.doc24KSupporting Information: Table S1. Clinical characteristics of NPC patients.
path_2997_sm_suppinfomatabs2.doc39KSupporting Information: Table S2. Primer sequences for qRT–PCR analysis of NOTCH pathway components and target genes.
path_2997_sm_suppinfomatabs3.doc77KSupporting Information: Table S3. Immunohistochemistry findings from primary NPC samples.
path_2997_sm_suppinfomation.doc32KSupporting Information: Legends to Figure S1 to S6
path_2997_sm_suppinfomethods.doc29KSupporting Information:

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.